Back
Emeren Group Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
42
SOL
Emeren Group
Last Price:
1.50
Seasonality Move:
6.68%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Sell
42
Emeren Group (SOL)
is a Sell
Is Emeren Group a Buy, Sell or Hold?
- The current Emeren Group [SOL] share price is $1.51. The Score for SOL is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- SOL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $247.00. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SOL Stock Price Chart
What is Emeren Group's stock price today?
-
The Emeren Group share price today is $1.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOL is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $247.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
SOL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 33.84 | Sell |
Chaikin Money Flow: | 174712 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.52 - 1.86) | Sell |
Bollinger Bands (100): | (1.68 - 2.1) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.83 | Buy |
Relative Strength Index (14 RSI): | 90.67 | Buy |
Chaikin Money Flow: | -365678 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.21 - 198.95) | Buy |
Bollinger Bands (100): | (137.63 - 173.99) | Buy |
SOL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.5 | Buy |
20-day SMA: | 1.62 | Sell |
50-day SMA: | 1.77 | Sell |
200-day SMA: | 2.24 | Sell |
8-day EMA: | 1.52 | Sell |
20-day EMA: | 1.62 | Sell |
50-day EMA: | 1.76 | Sell |
200-day EMA: | 2.31 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 198.72 | Buy |
20-day SMA: | 171.59 | Buy |
50-day SMA: | 157.67 | Buy |
200-day SMA: | 165.81 | Buy |
8-day EMA: | 210.85 | Buy |
20-day EMA: | 183.04 | Buy |
50-day EMA: | 165.87 | Buy |
200-day EMA: | 167.34 | Buy |
Emeren Group Earnings Growth & SOL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.40 per share, and an increase next year of $0.25 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Emeren Group Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |